Cargando…
Retraction Note: Ang II-AT2R increases mesenchymal stem cell migration by signaling through the FAK and RhoA/Cdc42 pathways in vitro
Autores principales: | Xu, Xiu-ping, He, Hong-li, Hu, Shu-ling, Han, Ji-bin, Huang, Li-li, Xu, Jing-yuan, Xie, Jian-feng, Liu, Ai-ran, Yang, Yi, Qiu, Hai-bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805407/ https://www.ncbi.nlm.nih.gov/pubmed/35101108 http://dx.doi.org/10.1186/s13287-022-02733-2 |
Ejemplares similares
-
Ang II-AT2R increases mesenchymal stem cell migration by signaling through the FAK and RhoA/Cdc42 pathways in vitro
por: Xu, Xiu-ping, et al.
Publicado: (2017) -
Retraction Note: Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression
por: Zhu, Gui-fang, et al.
Publicado: (2023) -
Retraction Note: Tert-butylhydroquinone lowers blood pressure in AngII-induced hypertension in mice via proteasome-PTEN-Akt-eNOS pathway
por: Xu, Bing-Can, et al.
Publicado: (2019) -
RhoA and Cdc42 in T cells: Are they targetable for T cell-mediated inflammatory diseases?
por: Guo, Fukun
Publicado: (2021) -
Retraction: Diabetes and Overexpression of proNGF Cause Retinal Neurodegeneration via Activation of RhoA Pathway
Publicado: (2017)